β-Catenin-Independent Activation of TCF1/LEF1 in Human Hematopoietic Tumor Cells through Interaction with ATF2 Transcription Factors

Authors

Luca Grumolato, Icahn School of Medicine at Mount Sinai
Guizhong Liu, Icahn School of Medicine at Mount Sinai
Tomomi Haremaki, CUNY Queens College
Sathish Kumar Mungamuri, Icahn School of Medicine at Mount Sinai
Phyllus Mong, Icahn School of Medicine at Mount Sinai
Gal Akiri, Icahn School of Medicine at Mount Sinai
Pablo Lopez-Bergami, Instituto de Medicina y Biología Experimental
Adriana Arita, Icahn School of Medicine at Mount Sinai
Youssef Anouar, University of Rouen
Marek Mlodzik, Icahn School of Medicine at Mount Sinai
Ze'ev A. Ronai, Sanford-Burnham Medical Research Institute
Joshua Brody, Icahn School of Medicine at Mount Sinai
Daniel C. Weinstein, CUNY Queens College
Stuart A. Aaronson, Icahn School of Medicine at Mount Sinai

Document Type

Article

Publication Date

August 2013

Abstract

The role of Wnt signaling in embryonic development and stem cell maintenance is well established and aberrations leading to the constitutive up-regulation of this pathway are frequent in several types of human cancers. Upon ligand-mediated activation, Wnt receptors promote the stabilization of β-catenin, which translocates to the nucleus and binds to the T-cell factor/lymphoid enhancer factor (TCF/LEF) family of transcription factors to regulate the expression of Wnt target genes. When not bound to β-catenin, the TCF/LEF proteins are believed to act as transcriptional repressors. Using a specific lentiviral reporter, we identified hematopoietic tumor cells displaying constitutive TCF/LEF transcriptional activation in the absence of β-catenin stabilization. Suppression of TCF/LEF activity in these cells mediated by an inducible dominant-negative TCF4 (DN-TCF4) inhibited both cell growth and the expression of Wnt target genes. Further, expression of TCF1 and LEF1, but not TCF4, stimulated TCF/LEF reporter activity in certain human cell lines independently of β-catenin. By a complementary approach in vivo, TCF1 mutants, which lacked the ability to bind to β-catenin, induced Xenopus embryo axis duplication, a hallmark of Wnt activation, and the expression of the Wnt target gene Xnr3. Through generation of different TCF1-TCF4 fusion proteins, we identified three distinct TCF1 domains that participate in the β-catenin-independent activity of this transcription factor. TCF1 and LEF1 physically interacted and functionally synergized with members of the activating transcription factor 2 (ATF2) family of transcription factors. Moreover, knockdown of ATF2 expression in lymphoma cells phenocopied the inhibitory effects of DN-TCF4 on the expression of target genes associated with the Wnt pathway and on cell growth. Together, our findings indicate that, through interaction with ATF2 factors, TCF1/LEF1 promote the growth of hematopoietic malignancies in the absence of β-catenin stabilization, thus establishing a new mechanism for TCF1/LEF1 transcriptional activity distinct from that associated with canonical Wnt signaling.

Comments

This work was originally published in PLoS Genetics, available at doi:10.1371/journal.pgen.1003603.